Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PHIO

Phio Pharmaceuticals Corp.

CIK 0001533040 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.04
↓ 0.04 (-3.70%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$12.08M
P/E Ratio
-1.11
EPS
-1.45
Dividend Yield
Not covered
52W Position
7%
Beta
1.47

Valuation multiples

Fwd P/E
0.57
PEG
Not covered
P/B
0.73
P/S
Not covered
EV/Revenue
Not covered
ROE
-66.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 7%
$0.81$4.19

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$8.70M
Total Assets
$21.49M
Free Cash Flow
-$7.99M

Recent news